Somerset, NJ – September 11, 2013
Dr. Cornell Stamoran, Founding Board Member of the Catalent Applied Drug Delivery Institute and Terry Robinson, Executive Director of the Institute, are to present at the 52nd Annual Eastern Pharmaceutical Technology Meeting (EPTM).
Dr. Stamoran’s presentation is titled “Don’t Leave Money on the Table: Collaborative Product Development for Better Patient Outcomes,” and will highlight payer/physician/patient perspectives on how dose form design and dosing regimen complexity impact patient outcomes and market uptake. The session will include real world examples of optimization, and describe how collaboration with both drug delivery providers and academia at an early stage of development may yield better R&D returns on investment and reduce clinical and market uptake risk.
Ms. Robinson will follow Dr. Stamoran’s presentation, and will focus on “The Catalent Applied Drug Delivery Institute: Building Bridges for Better Patient Outcomes.”
The conference’s central theme is “The Future of Pharmaceutical Business-Academic-Industry Collaboration for Better Innovation,” and takes place in Basking Ridge, NJ, on Friday, September 20th 2013.
Dr. Stamoran has spent nearly 25 years engaged with the healthcare industry, and has experienced the realities of patient adherence and outcomes enhancement from almost every stakeholder perspective: from direct engagement with retail and hospital pharmacists; medical professionals; specialty pharmacies and clinics; and pharmacy benefit managers and payers. He has directly participated in adherence and outcomes enhancement strategies for more than 150 drugs over the last 10 years.
Terry Robinson was named Executive Director of the Catalent Applied Drug Delivery Institute in February 2013. Ms. Robinson is responsible for establishing industry relations, academic programs, education and technology development. Ms. Robinson has over 25 years of experience in pharmaceutical strategy, development and account management. Prior to Catalent, Ms. Robinson worked for Amgen, Inc. as a Sr. Manager of Corporate Accounts. Previously, she held a number of positions at Eli Lilly & Company serving as a member of their Business to Business team focused on retail drug chains, drug wholesalers and hospital health systems.
For more information on the EPTM Annual Meeting go to: www.eptm.us.
About The Catalent Applied Drug Delivery Institute
Catalent’s Applied Drug Delivery Institute was founded to serve as a link between industry and academia, advance education and training in drug delivery in academia and the industry, accelerate adoption of applied drug delivery technologies to develop better treatments and foster industry collaboration on major issues pertaining to drug development, formulation and delivery. The Institute is pursuing a multi-tiered approach of seed funding, strategic counsel, and educational programs to advance the adoption of emerging technologies. To learn more about the Catalent Institute & how to get involved visit: www.drugdeliveryinstitute.com.
Catalent Pharma Solutions is the global leader in development solutions and advanced drug delivery technologies, providing world-wide clinical and commercial supply capabilities for drugs, biologics and consumer health products. With over 75 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable product supply. Catalent employs approximately 8,500 people, including over 1,000 scientists, at nearly 30 facilities across 5 continents and generates more than $1.7 billion in annual revenue. Catalent is headquartered in Somerset, N.J. For more information, visit www.catalent.com.
More products. Better treatments. Reliably supplied.™